M&A Deal Summary

Hilco Industrial Acquisitions Acquires Legacy Pharmaceutical

On April 29, 2021, Hilco Industrial Acquisitions acquired life science company Legacy Pharmaceutical

Acquisition Highlights
  • This is Hilco Industrial Acquisitions’ 1st transaction in the Life Science sector.
  • This is Hilco Industrial Acquisitions’ 1st transaction in Switzerland.

M&A Deal Summary

Date 2021-04-29
Target Legacy Pharmaceutical
Sector Life Science
Buyer(s) Hilco Industrial Acquisitions
Deal Type Add-on Acquisition

Target

Legacy Pharmaceutical

Birsfelden, Switzerland
Legacy Pharmaceutical is a global contract manufacturer of sterile/aseptic and nonsterile pharmaceutical products in liquid and powder form. Since its founding, the company has been part of the long-standing Swiss tradition of excellence, quality, and reliability in the pharmaceutical industry. It upholds quality standards and virtues such as excellence in service, reliability, social responsibility, and compliance. These are virtues and characteristics that have made Basel known as a pharmaceutical center and that enable to be a reliable service provider for customers, who are active around the world. Legacy Pharmaceutical is based in Birsfelden, Switzerland.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hilco Industrial Acquisitions

Amsterdam, Netherlands

Category Company
Founded 2014
Sector Business Services
DESCRIPTION

Hilco Industrial Acquisitions was formed in 2014 by Hilco Industrial LLC and CBI (Core Business Industries) as a joint venture to buy distressed industrial assets, liquidate those which are no longer needed, and continue the lucrative operations. Hilco Industrial Acquisitions is based in Amsterdam, Netherlands.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2021 M&A 1 of 1